MetLife Investment Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,969
| Closed | -$141K | – | 2921 |
|
|
2024
Q1 | $141K | Hold |
1,969
| – | – | ﹤0.01% | 2372 |
|
|
2023
Q4 | $391K | Hold |
1,969
| – | – | ﹤0.01% | 1830 |
|
|
2023
Q3 | $262K | Hold |
1,969
| – | – | ﹤0.01% | 2041 |
|
|
2023
Q2 | $295K | Hold |
1,969
| – | – | ﹤0.01% | 2027 |
|
|
2023
Q1 | $289K | Buy |
1,969
+243
| +14% | +$35.7K | ﹤0.01% | 1992 |
|
|
2022
Q4 | $273K | Hold |
1,726
| – | – | ﹤0.01% | 2047 |
|
|
2022
Q3 | $332K | Buy |
1,726
+111
| +7% | +$21.4K | ﹤0.01% | 1924 |
|
|
2022
Q2 | $236K | Buy |
1,615
+236
| +17% | +$34.5K | ﹤0.01% | 2199 |
|
|
2022
Q1 | $243K | Buy |
1,379
+509
| +59% | +$89.5K | ﹤0.01% | 2239 |
|
|
2021
Q4 | $256K | Hold |
870
| – | – | ﹤0.01% | 1907 |
|
|
2021
Q3 | $216K | Hold |
870
| – | – | ﹤0.01% | 2040 |
|
|
2021
Q2 | $221K | Buy |
+870
| New | +$221K | ﹤0.01% | 2100 |
|
|
2020
Q4 | – | Sell |
-668
| Closed | -$172K | – | 2307 |
|
|
2020
Q3 | $172K | Hold |
668
| – | – | ﹤0.01% | 1949 |
|
|
2020
Q2 | $155K | Buy |
+668
| New | +$155K | ﹤0.01% | 2043 |
|